ethanamine Hydrochloride - Springer Link

2 downloads 0 Views 171KB Size Report
Adamantane derivatives exhibit a broad spectrum of biological activity. The antiviral drug rimantadine. [1, 1-(1-adamantyl)ethanamine hydrochloride] is used.
ISSN 1070-4280, Russian Journal of Organic Chemistry, 2015, Vol. 51, No. 1, pp. 22–25. © Pleiades Publishing, Ltd., 2015. Original Russian Text © R.I. Khusnutdinov, N.A. Shchadneva, L.F. Khisamova, U.M. Dzhemilev, 2015, published in Zhurnal Organicheskoi Khimii, 2015, Vol. 51, No. 1, pp. 29–32.

Synthesis of 3-(1-Aminoethyl)adamantan-1-ol by Hydroxylation of 1-(1-Adamantyl)ethanamine Hydrochloride (Rimantadine) R. I. Khusnutdinov, N. A. Shchadneva, L. F. Khisamova, and U. M. Dzhemilev Institute of Petrochemistry and Catalysis, Russian Academy of Sciences, pr. Oktyabrya 141, Ufa, 450075 Bashkortostan, Russia e-mail: [email protected] Received December 13, 2013

Abstract—A procedure has been developed for the selective synthesis of 3-(1-aminoethyl)adamantan-1-ol by hydroxylation of 1-(1-adamantyl)ethanamine hydrochloride with the system H2O–CBrCl3 in the presence of W(CO)6 activated by pyridine.

DOI: 10.1134/S1070428015010042 Adamantane derivatives exhibit a broad spectrum of biological activity. The antiviral drug rimantadine [1, 1-(1-adamantyl)ethanamine hydrochloride] is used for the prophylactics and early treatment of influenza [1]. It was found that the presence of a hydroxy group in the adamantane core reduces the toxicity and extends the spectrum of antiviral activity [2, 3]. This tendency is well seen with 3-(1-aminoethyl)adamantan-1-ol (2) as an example, which showed a high activity against herpes viruses. Known methods of synthesis of 3-(1-aminoethyl)adamantan-1-ol include several steps [4–7]. One procedure is based on the oxidation of 1 with a mixture of nitric and sulfuric acids [7], which makes isolation of the target product difficult. We previously [8, 9] found that the system H2O– CBr 4 (CBrCl 3 , CCl 4 )–Mo(CO) 6 ensures selective hydroxylation of adamantane and its derivatives. In this system, the active oxidizing species is hypobromous (or hypochlorous) acid generated in situ from H2O and CBr4, CBrCl3, or CCl4 in the presence of a catalyst. In the present work we continued search for efficient catalysts among Group V–VIII transition metal compounds, which could favor at low concentration

(1–3 mol %) selective oxidation of 1-(1-adamantyl)ethanamine hydrochloride (1) to 3-(1-aminoethyl)adamantan-1-ol (2). Among the examined Ni, Mn, Cu, Pd, Fe, Cr, Co, Mo, and W salts and complexes, tungsten hexacarbonyl W(CO)6 activated by pyridine showed an appreciable catalytic activity in the oxidation of 1 with H2O–CBrCl3 (Scheme 1, Table 1). In this case, the hydroxylation of 1-(1-adamantyl)ethanamine hydrochloride (1) smoothly afforded the desired product, whereas the free base, 1-(1-adamantyl)ethanamine (3) reacted with CBrCl3 and water to produce 1-(3-hydroxyadamantan-1-yl)ethanone (4) (Scheme 2). When CBrCl3 was replaced by CBr4, the reaction direction changed toward the formation of 1-(3-bromoadamantan-1-yl)ethanamine (5). The oxidation of 1 in the presence of W(CO)6 at 130–140°C in 3 h afforded 85–86% of 3-(1-aminoethyl)adamantan-1-ol hydrochloride (2), the conversion of 1 being 90–95%. 1-(3-Bromoadamantan-1-yl)ethanamine (5) formed as by-product was separated from compounds 1 and 2 by column chromatography on silica gel using hexane–methylene chloride (2 : 1) as eluent. The molar ratio W(CO) 6 –AdCH(NH 2 )CH 3– BrCCl3–H2O was (3–5) : 100 : 500 : 4000.

Scheme 1. Me

+

CBrCl3 +

W(CO)6, pyridine 140°C, 3 h

H 2O

Me HO

NH2 · HCl 1

NH2 · HCl 2

22

SYNTHESIS OF 3-(1-AMINOETHYL)ADAMANTAN-1-OL

23

Table 1. Oxidation of 1-(1-adamantyl)ethanamine hydrochloride (1) with halomethane–H2O in the presence of different catalysts

Catalyst

Yield, %

Molar ratio catalyst– Temperature, Reaction Conversion Halomethane °C time, h of 1, % 1–halomethane–H2O

2

5

di- and tribromo derivatives

No catalyst

CBrCl3

0 : 100 : 500 : 4000

160

6

020

06

10

04

Ni(acac)2

CBrCl3

1 : 100 : 500 : 4000

160

6

048

16

04

28

Mn(acac)3

CBrCl3

3 : 100 : 500 : 4000

160

6

100

25

11

64

Cu(acac)2

CBrCl3

3 : 100 : 500 : 4000

160

6

048

20

13

15

Pd(acac)2

CBrCl3

3 : 100 : 300 : 4000

160

6

068

28

12

28

Fe(acac)3

CBrCl3

3 : 100 : 100 : 4000

160

6

066

22

08

36

CuBr2

CBrCl3

3 : 100 : 100 : 4000

160

6

078

16

56

06

CoCl2

CBrCl3

3 : 100 : 100 : 4000

140

3

057

20

13

24

CoCl2

CBrCl3

3 : 100 : 100 : 4000

160

5

060

31

17

12

Mo(CO)6

CBrCl3

3 : 100 : 100 : 4000

160

6

081

50

09

22

Mo(CO)6

CBrCl3

3 : 100 : 300 : 4000

140

5

084

76



08

Mo(CO)6

CBrCl3

3 : 100 : 500 : 4000

140

5

094

65

8

21

Mo(CO)6–Py

CBrCl3

3 : 100 : 500 : 4000

140

5

100

85

10

05

W(CO)6

CBrCl3

3 : 100 : 100 : 4000

130

6

095

73

12

08

W(CO)6

CBr4

3 : 100 : 100 : 4000

130

3

088

34

26

28

W(CO)6 –Py

CBrCl3

3 : 100 : 500 : 4000

140

3

091

86

05



Mn2(CO)10

CBrCl3

3 : 100 : 500 : 4000

140

3

089

54

10

25

Co2(CO)8

CBrCl3

3 : 100 : 500 : 4000

140

3

089

41

12

36

Fe2(CO)9

CBrCl3

3 : 100 : 500 : 4000

140

3

082

60

11

11

Cr(CO)6

CBrCl3

3 : 100 : 500 : 4000

140

3

084

51

16

17

In order to improve the yield of 2 and reaction selectivity we examined the effect of the nature of activating ligands on the reaction course (Table 2). In all cases, pyridine turned out to be the most efficient ligand; in the presence of pyridine, the yield of bromo derivative 5 was minimal (5%). The optimal pyridine–W(CO)6 ratio was estimated at 1 : 1. Increase of the pyridine concentration did not affect the selectivity and the yield of 2, but the isolation procedure was complicated due to poor layer separation, which resulted in reduced yield.

It should be noted that addition of activating ligands favored reduction of the reaction temperature, so that the reactions can be performed in an open system, at 80–85°C (7 h) at a W(CO)6–Py–1–CBrCl3– H2O molar ratio of 3 : 3 : 100 : 1000 : 16000. According to the GLC data, under these conditions the major product was 3-(1-aminoethyl)adamantan-1-ol hydrochloride (2) whose yield was 57% at a conversion of 1 of 74–75%. The by-products (~18–20%) were di- and tribromo(chloro) derivatives of 1, as well as dihydroxy derivatives which were identified by GC/MS.

Scheme 2. Me

+

CBrCl3 +

H 2O

W(CO)6, pyridine 140°C, 3 h

NH2 3

RUSSIAN JOURNAL OF ORGANIC CHEMISTRY Vol. 51 No. 1 2015

Me HO

O 4

KHUSNUTDINOV et al.

24

Table 2. Oxidation of 1-(1-adamantyl)ethanamine hydrochloride (1) with CBrCl3–H2O in the presence of W(CO)6 and different ligands L [W(CO)6–L–1–CBrCl3–H2O 3 : 3 : 100 : 500 : 4000] Yield, %

Ligand L

Temperature, °C

Reaction time, h

Conversion of 1, %

2

5

di- and tribromo derivatives

N-Hydroxyphthalimide

125

6

95

53

12

30

3-Methylpyridine

140

3

84

50

18

16

4-Methylpyridine

140

3

82

60

12

10

Morpholine

140

2

74

42

10

22

N,N-Dimethylacetamide

140

2

90

53

15

22

Pyridine

130

6

90

78

12



Pyridine

140

3

91

86

05



Acetonitrile

140

3

90

72

15

03

Triethylamine

140

3

51

45

06



Diethylamine

140

3

57

52

07



Triphenylphosphine

140

3

65

38

05

14

Triphenyl phosphite

140

3

54

25

09

20

Thus, tungsten hexacarbonyl activated by pyridine is an efficient catalyst for the selective synthesis of 3-(1-aminoethyl)adamantan-1-ol hydrochloride (2) by hydroxylation of 1-(1-adamantyl)ethanamine hydrochloride (1) with the system H2O–CBrCl3. EXPERIMENTAL The IR spectra were recorded in KBr or mineral oil on a Bruker Vertex 79V spectrometer. The 1H and 13 C NMR spectra were measured on a Bruker Avance400 spectrometer at 400.13 and 100.62 MHz, respecttively, using CDCl3 as solvent and tetramethylsilane as reference. The mass spectra were obtained on a Shimadzu GCMS-QP2010Plus instrument (SPB-5 capillary column, 30 m × 0.25 mm; carrier gas helium; oven temperature programming from 40 to 300°C at a rate of 8 deg/min; injector temperature 280°C; ion source temperature 200°C; electron impact, 70 eV). The elemental compositions were determined on a Carlo Erba 1106 analyzer. The progress of reactions was monitored, the purity of the isolated compounds was checked, and the product composition was determined, by GLC on a Khrom-5 chromatograph (1.2 m × 3-mm column packed with 5% of SE-30 on Chromaton N-AW-HMDS; oven temperature programming from 50 to 280°C at a rate of 8 deg/min; carrier gas helium); adamantan-1-ol was used as internal stan-

dard; the calibration factor for 3-(1-aminoethyl)adamantan-1-ol (2) was 3.92. The reagents used had a purity of no less than 99%. 1-(1-Adamantyl)ethanamine hydrochloride (1), bromotrichloromethane, and W(CO)6 were commercial products (from Acros Organics). Commercial N-hydroxylphthalimide, 3-methylpyridine, 4-methylpyridine, morpholine, N,N-dimethylacetamide, pyridine, acetonitrile, triethylamine, diethylamine, triphenylphosphine, and triphenyl phosphite were preliminarily purified by distillation or recrystallization according to the procedures described in [10]. The reactions were carried out in a 20-mL glass ampule or a 17-mL stainless-steel high-pressure micro reactor which was charged under argon with 0.3 mmol of W(CO)6, 10 mmol of 1-(1-adamantyl)ethanamine hydrochloride (1), 50 mmol of bromotrichloromethane, and 550 mmol of water. The reactor was hermetically closed (the ampule was sealed) and heated for 3 h at 140°C under stirring. When the reaction was complete, the reactor (ampule) was cooled to room temperature, and the mixture was dissolved in hexane and washed with methylene chloride where the major product is soluble. 3-(1-Aminoethyl)adamantan-1-ol hydrochloride (2). Yield 86%, mp 323–324°C. IR spectrum: ν 2500–3500 cm–1 (NH, OH). 1H NMR spectrum, δ, ppm: 1.57 m (2H, 2-H), 1.51 m (6H, 6-H, 8-H, 9-H),

RUSSIAN JOURNAL OF ORGANIC CHEMISTRY Vol. 51 No. 1 2015

SYNTHESIS OF 3-(1-AMINOETHYL)ADAMANTAN-1-OL

2.27 m (2H, 5-H, 7-H), 1.61–1.76 m (4H, 8-H, 10-H), 1.24 (2H, 4-H, 10-H), 1.24 d (3H, CH3, J = 6.8 Hz), 3.09 q (1H, CH, J = 6.8 Hz), 7.20 s (3H, NH 3+ ). 13 C NMR spectrum (free base, mp 110–112°C), δ C, ppm: 16.56 (CH3), 28.32 (C5, C7), 35.61 (C6), 36.69 (C4), 36.88 (C9), 44.80 (C8, C10), 45.74 (C3), 55.54 (CHNH2), 66.42 (C1). 1-(3-Hydroxyadamantan-1-yl)ethanone (4). Yield 78%, mp 86–87°C (from hexane); published data [6]: mp 89–91°C (from EtOAc–hexane). IR spectrum, ν, cm–1: 3395 (OH), 1680 (C=O). 13C NMR spectrum, δC, ppm: 24.59 (CH3), 30.16 (C5, C7), 35.02 (C6), 37.03 (C8, C10), 44.23 (C4, C9), 45.63 (C2), 49.90 (C1), 68.29 (C3), 212.74 (C=O). Mass spectrum, m/z (Irel, %): 194 (7) [M]+, 152 (9), 151 (100), 133 (7), 109 (7), 107 (19), 95 (36), 93 (48), 91 (7), 81 (11), 79 (8), 77 (9), 67 (11), 65 (7), 59 (9), 55 (9), 43 (38), 41 (12), 39 (9), 29 (7). Found, %: C 74.05; H 9.29. C12H18O2. Calculated, %: C 74.19; H 9.34. M 194.270 1-(3-Bromoadamantan-1-yl)ethanamine (5). Yield 64%. 13C NMR spectrum, δC, ppm: 17.44 (CH3), 32.36 (C3, C8), 32.6 (C5), 34.95 (C10), 39.3 (C4), 48.85 (C2, C7), 49.77 (C6), 52.97 (C11), 61.05 (C1). Found, %: C 55.52; H 8.08; N 5.17. C12H21BrN. Calculated, %: C 73.48; H 10.71; N 6.95. This study was performed under financial support by the President of the Russian Federation (program for support of young scientists and post-graduate students engaged in advanced research and developments in the priority fields of modernization of the Russian economics for 2013–2015, project no. SP-4810.2013.4).

25

REFERENCES 1. Morozov, I.S., Petrov, V.I., and Sergeeva, S.A., Farmakologiya adamantanov (Pharmacology of Adamantanes), Volgograd: Volgogr. Med. Akad., 2001. 2. Bagrii, E.I., Adamantany (Adamantanes), Moscow: Nauka, 1989. 3. Vot’yakov, V.I., Boreko, E.I., and Vladyko, G.V., Perspektivy razvitiya khimii karkasnykh soedinenii i ikh primenenie v otraslyakh promyshlennosti (Prospects in the Development of the Chemistry of Cage Compounds and Their Industrial Applications), Kiev, 1986, p. 12. 4. Kozushko, G.I., Mizdokh, O., Vot’yakov, V.I., Rusaev, V.A., Danilenko, V.F., Stepanova, G.U., and Danilenko, K.I., Farm. Zh. (Kiev), 1984, p. 37. 5. Stetter, H. and Meyer, J., Chem. Ber., 1962, vol. 95, p. 667. 6. Manchand, P.S., Cerrut, R.L., Martin, J.A., Hill, C.H., Merett, J.H., Keech, E., Belshe, R.B., Connell, E.V., and Sim, J.S., J. Med. Chem., 1990, vol. 33, p. 1992. 7. Lavrova, L.N., Indulen, M.K., Ryazantseva, G.M., Korytnyi, V.S., and Yashunskii, V.G., Pharm. Chem. J., 1990, vol. 24, no. 1, p. 35. 8. Khusnutdinov, R.I., Shchadneva, N.A., Burangulova, R.Yu., Oshnyakova, T.M., and Dzhemilev, U.M., Russ. J. Org. Chem., 2007, vol. 43, p. 623. 9. Khusnutdinov, R.I., Shchadneva, N.A., Mukhametshina, L.F., and Dzhemilev, U.M., Russ. J. Org. Chem., 2009, vol. 45, p. 1137. 10. Becker, H.G.O., et al., Organikum. Organischchemisches Grundpraktikum, Berlin: Wissenschaften, 1976, 15th edn. Translated under the title Organikum, Moscow: Mir, 1979, vol. 2, p. 254.

RUSSIAN JOURNAL OF ORGANIC CHEMISTRY Vol. 51 No. 1 2015